Anogen is the trade name of YES Biotech Laboratories Ltd., a Canadian-based company located near Toronto, Ontario. Anogen has been producing antibody products for research applications since its inco...
Anogen is the trade name of YES Biotech Laboratories Ltd., a Canadian-based company located near Toronto, Ontario. Anogen has been producing antibody products for research applications since its incorporation in 1989, and specializes in the research and development of biopharmaceutical and immunodiagnostic products based on monoclonal antibody technology. Over the past decade, Anogen has established a large hybridoma cell bank and manufactures over three hundred monoclonal antibodies specific for various cytokines, growth factors, hormones, cell membrane proteins, tumor markers, and viral proteins. Anogen also manufactures nearly fifty different immunoassay kits as well as polyclonal antibodies, matched antibody pairs, immunoglobulins, hybridomas, bioactive peptides, and recombinant proteins, all of which are marketed worldwide. Anogen is committed to developing and commercializing novel antibody-based biopharmaceuticals for the treatment of cancer, autoimmune, inflammatory and cardiovascular diseases. The three major strategies employed by Anogen include: (1) Strategic alliance and partnering with established pharmaceutical companies for product development, regulatory filing, and marketing, (2) Strong collaborations and associations with academic institutions for acquiring cutting-edge technology and acceleration of early stage product research and development, and (3) Licensing and acquisition of new concepts, technologies, and products at early stages of development in order to continually fuel Anogen's product pipeline.